Methylgene, Inc.
Records under this name other than the patents Methylgene, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,772,247 | Substituted thieno[3,2-d]pyridines as inhibitors of the VEGF receptor and HGF receptor Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,389,541 | Inhibitors of Protein Tyrosine Kinase Activity Formerly held In force · High confidence | In force | High confidence | |
| US 8,569,503 | Processes and Intermediates for Preparing Fused Heterocyclic Kinase Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 8,846,927 | Inhibitors of Protein Tyrosine Kinase Activity Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,018,378 | Processes and Intermediates for Preparing Fused Heterocyclic Kinase Inhibitors Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,030,344 | Inhibitors of histone deacetylase Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,404,846 | Inhibitors of Protein Tyrosine Kinase Activity Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,093,264 | Fused Heterocycles as Inhibitors of VEGF Receptor and HGF Receptor Signaling Formerly held In force · High confidence | In force | High confidence | |
| US 8,796,330 | Inhibitors of histone deacetylase and prodrugs thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,096,565 | Inhibitors of histone deacetylase Formerly held In force · From the USPTO record | In force | From the USPTO record |